Pregnancy and Hereditary Antithrombin Deficiency: New Study Reveals Critical Clearance Peaks at Delivery
Thrombosis Update published on its X:
“A new case study in Thrombosis Update on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery.”
Title: Antithrombin supplementation to prevent venous thromboembolism: A case of hereditary antithrombin deficiency with increased antithrombin clearance during pregnancy and peripartum
Autors: Ayako Kaneda Takeuchi, Tomoaki Oda, Mei Kitamoto , Emiyu Fujiwara, Kenta Kawai, Megumi Narumi, Yoshimasa Horikoshi, Masako Matsumoto, Yukiko Kohmura-Kobayashi, Naomi Furuta-Isomura, Toshiyuki Uchida, Kazunao Suzuki, Naohiro Kanayama, Hiroaki Itoh, Naoaki Tamura.
Two-Sentence Summary (Analytical): A newly published case study highlights that antithrombin clearance significantly increases during the first and third trimesters in pregnant women with hereditary antithrombin deficiency (HATD), peaking around the time of delivery. These findings emphasize the need for dynamic monitoring of antithrombin levels throughout pregnancy to prevent thromboembolic complications in this high-risk population.
You can explore more detailed information on Hemostasis Today.
-
Jun 15, 2025, 11:1710 Posts Not to Miss from EHA 2025
-
Jun 15, 2025, 09:44WFH Shared Decision-Making Tool: Help Improve Hemophilia Care
-
Jun 15, 2025, 06:52Pregnancy and Hereditary Antithrombin Deficiency: New Study Reveals Critical Clearance Peaks at Delivery
-
Jun 13, 2025, 23:12The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery
-
Jun 13, 2025, 08:19Decoding the Inflammatory–Metabolic Axis in Atherosclerosis: A New Frontier in Cardiovascular Prevention- by Atherosclerosis
-
Jun 15, 2025, 09:32Silent Threat: Underrated Risk of Thrombosis in IBD Outpatients Revealed by New Data - Thrombosis Update
-
Jun 13, 2025, 07:543-Year Outcomes of AAV Gene Therapy in Hemophilia B: Study Published in NEJM Shows Long-Term Factor IX Expression
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation